Dubé I, Dixon J, Beckett T, Grossman A, Weinstein M, Benn P, McKeithan T, Norman C, Pinkerton P
University of Toronto Hospitals Cancer Cytogenetics Program, Ontario, Canada.
Genes Chromosomes Cancer. 1989 Sep;1(1):106-11. doi: 10.1002/gcc.2870010116.
We report the sublocalization of the breakpoint in chromosome 22 in 33 patients with chronic myeloid leukemia (CML) who also had unusual marrow cytogenetics. In 23 patients, the leukemic clones were characterized by Philadelphia (Ph1) chromosomes that arose through complex translocations that involved three or more chromosomes. In the remaining ten patients, there were no detectable Ph1 chromosomes despite molecular evidence for the presence of rearrangements in the major breakpoint cluster region (bcr) of chromosome 22 in all cases. There was no significant difference between the two groups with respect to location of the breakpoints within the bcr. When these two groups of patients were combined, there was a significant excess of breakpoints in one segment of the bcr when compared to the distribution of breakpoints seen in 119 patients with simple 9;22 translocations. The difference in breakpoint distributions did not appear to be entirely attributable to differences between groups in disease duration at the time of study. These data support the notion that the unusual genetic recombinations that give rise to BCR/ABL fusion genes in CML involve specific DNA sequences of BCR (and possibly ABL) and additional, recombinogenic sequences, at least some of which are present in loci known to be nonrandomly involved in complex Ph1 translocations.
我们报告了33例慢性髓性白血病(CML)患者22号染色体断点的亚定位情况,这些患者同时伴有异常的骨髓细胞遗传学特征。在23例患者中,白血病克隆的特征是费城(Ph1)染色体,其通过涉及三条或更多条染色体的复杂易位产生。在其余10例患者中,尽管所有病例在分子水平上均有证据表明22号染色体主要断点簇区域(bcr)存在重排,但未检测到Ph1染色体。两组患者bcr内断点的位置没有显著差异。当将这两组患者合并时,与119例具有简单9;22易位的患者的断点分布相比,bcr的一个片段中的断点明显过多。断点分布的差异似乎并不完全归因于研究时两组患者疾病持续时间的差异。这些数据支持这样的观点,即CML中产生BCR/ABL融合基因的异常基因重组涉及BCR(可能还有ABL)的特定DNA序列以及其他重组序列,其中至少一些存在于已知非随机参与复杂Ph1易位的基因座中。